We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+3.44%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$80.2B
AUM Growth
+$2.8B
Cap. Flow
+$296M
Cap. Flow %
0.37%
Top 10 Hldgs %
9.83%
Holding
4,048
New
499
Increased
1,419
Reduced
1,452
Closed
416

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$667M
2
NVDA icon
NVIDIA
NVDA
+$584M
3
COP icon
ConocoPhillips
COP
+$432M
4
AMZN icon
Amazon
AMZN
+$418M
5
JNJ icon
Johnson & Johnson
JNJ
+$377M

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$836M
2
META icon
Meta Platforms (Facebook)
META
+$525M
3
AAPL icon
Apple
AAPL
+$453M
4
CELG
Celgene Corp
CELG
+$349M
5
PFE icon
Pfizer
PFE
+$306M

Sector Composition

Rank Sector Weight
1 Technology 16.27%
2 Consumer Discretionary 13.7%
3 Healthcare 13.3%
4 Industrials 7.34%
5 Financials 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QQQ icon
3776
Invesco QQQ Trust
QQQ
$486B
-2,624
Closed -$471K
QURE icon
3777
uniQure
QURE
$3.36B
-122,660
Closed -$7.82M
RACE icon
3778
PUT
Ferrari
RACE
$76.7B
-28,700
Closed -$3.84M
RAMP icon
3779
CALL
LiveRamp
RAMP
$2.28B
-3,700
Closed -$202K
RDHL
3780
Redhill Biopharma
RDHL
$3.83M
-14
Closed -$113K
REGN icon
3781
CALL
Regeneron Pharmaceuticals
REGN
$85.9B
-22,700
Closed -$9.32M
RES icon
3782
RPC Inc
RES
$1.41B
-60,454
Closed -$690K
RGA icon
3783
PUT
Reinsurance Group of America
RGA
$15.9B
-2,900
Closed -$412K
RJF icon
3784
PUT
Raymond James Financial
RJF
$33.7B
-37,350
Closed -$2M
RKDA icon
3785
Arcadia Biosciences
RKDA
$1.1M
-266
Closed -$74K
RLI icon
3786
RLI Corp
RLI
$6B
-15,418
Closed -$553K
RNAC icon
3787
Cartesian Therapeutics
RNAC
$304M
-1,022
Closed -$73K
RNR icon
3788
RenaissanceRe
RNR
$13.4B
-1,800
Closed -$296K
RUN icon
3789
Sunrun
RUN
$2.21B
-54,852
Closed -$771K
RYAAY icon
3790
CALL
Ryanair
RYAAY
$28.9B
-8,500
Closed -$255K
RYAM icon
3791
PUT
Rayonier Advanced Materials
RYAM
$586M
-75,000
Closed -$1.02M
SBS icon
3792
Sabesp
SBS
$16.2B
-1,125,447
Closed -$2.31M
SGMO
3793
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
-179,575
Closed -$1.91M
SHEN icon
3794
Shenandoah Telecom
SHEN
$683M
-9,485
Closed -$393K
SHEN icon
3795
PUT
Shenandoah Telecom
SHEN
$683M
-9,100
Closed -$404K
SID icon
3796
Companhia Siderúrgica Nacional
SID
$1.3B
-18,102
Closed -$74K
SIRI icon
3797
SiriusXM
SIRI
$9.67B
-14,930
Closed -$846K
SKX
3798
DELISTED
Skechers
SKX
-31,485
Closed -$1.06M
SKX
3799
PUT
DELISTED
Skechers
SKX
-7,500
Closed -$252K
SLG icon
3800
CALL
SL Green Realty
SLG
$4.07B
-32,333
Closed -$2.81M

Similar funds

David Shaw's Q2 2019 Portfolio in Review

As of Q2 2019, David Shaw held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

David Shaw's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • David Shaw's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
  • David Shaw added most to Alibaba in Q2 2019, an estimated $667M increase.
  • David Shaw's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
  • David Shaw fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
  • David Shaw's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
  • David Shaw opened 499 new positions and closed 416 in Q2 2019.
  • David Shaw's portfolio value rose 3.6% quarter-over-quarter to $80.2B.

Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.